Drawing for AKORN

USPTO serial 86937435

AKORN

Reviewed by CopyMark Law Group

Reg. 5076962Status 710
Filing date
Status date
Registration date
Nov 8, 2016
Examiner
OLANDRIA, WARREN
Law office
Historical data usage

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with AKORN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark A. Paskar

Mark A. Paskar Bryan Cave Leighton Paisner LLP211 North Broadway, Suite 3600St. Louis, MO 63102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products and preparations, namely, inhalants, injectables, nasal sprays and mists, oral liquids, oral solids and topicals for sterile aqueous ophthalmic solutions; ocular anesthetics; ophthalmic solutions for the treatment of elevated intraocular pressure in individuals with ocular hypertension or open-angle glaucoma; sterile indocyanine green for use as a cardiac diagnostic aid, a hepatic diagnostic aid and as a retinal diagnostic aid; hypnotic sedative anesthetic compounds; mydriatics; pharmaceutical preparations for the treatment of respiratory conditions; oral analgesics; oral analgesics in solution or liquid form; analgesic preparations; spinal anesthetics; anti-diarrheal agents; schedule III prescription synthetic narcotics; anxiolytics; anti-seizure medications; topical anesthetics; pharmaceutical preparations for treatment of arsenic, gold and mercury poisoning and acute lead poisoning; pharmaceutical preparations for treatment of opioid dependence; antibacterials, namely, antibacterial cleaners, antibacterial hand lotions, and antibacterial pharmaceuticals; pharmaceutical agents for treatment of respiratory ailments, prevention of endometrial hyperplasia and secondary amenorrhea; corticosteroid formulations indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and musculoskeletal conditions; antiviral agents; anti-infectives; vitamins; dietary and nutritional supplements; magnesium supplements; antacids; pharmaceutical preparations for relief of nasal congestion, sinus pressure and sinus headache, nasal sprays; topicals for the treatment of arthritis, joint pain, back pain, foot pain and muscle pain; preparations for the relief of pain; pain relief medication; arthritis and joint pain preparations; cough suppressants and expectorants; cough drops and syrups; preparations for relief of symptoms of common colds and influenza; tablets, swabs, nasal sprays and effervescent preparations for treating colds and flu; tablets, swabs, nasal sprays and effervescent preparations for preventing colds and flu; medicated foot creams, lotions and ointments; medicated skin creams and lotions, including anti-itch creams; medicated tinctures and ointments for lip and skin care; eye drops; lubricant eye drops; eyelid cleanser, skin care around the eyelid; eye nutrition; contact lens comfort drops, veterinary pharmaceuticals; veterinary pharmaceuticals and preparations, namely, xylazine, ketamine, and reversing agents and antagonists for use in horses; veterinary pain relief medications, anesthetics and sedatives; veterinary ophthalmics; veterinary eye wash; veterinary eye lubricants and eye dropsSECTION 8 - CANCELLEDJan 20, 1971

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 29, 2024NCS8NOTICE OF CANCELLATION SEC. 8 EMAILED—
Jun 29, 2024C8..CANCELLED SEC. 8 (6-YR)—
Dec 12, 2023PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Oct 27, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 21, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 12, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 8, 2023ES8RTEAS SECTION 8 RECEIVED—
Feb 22, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 22, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 22, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 22, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 10, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 8, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 16, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 16, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 1, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 19, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 31, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 10, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 2, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 18, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 21, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 8, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 23, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 23, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 3, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 21, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 14, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 14, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 14, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 7, 2016ALIEASSIGNED TO LIE—
Jun 30, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2016DOCKASSIGNED TO EXAMINER—
Mar 16, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 15, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance